Aptevo Therapeutics reports strong remission rates in AML patients using mipletamig plus ven/aza, with Cohort 2 enrollment ...

Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of careTriplet Combination with mipletamig continues to outperform do ...

In December 2024, the National Comprehensive Cancer Network® (NCCN) added AUCATZYL (obecabtagene autoleucel) to its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the treatment of ...

Scientists at the Allen Institute have made a major breakthrough in research for people living with Dravet Syndrome, which is ...

The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...

Hello ladies and gentlemen and welcome to the Autolus Therapeutics call to discuss its full year 2024 financial results and business updates. As a reminder, this conference call is being recorded. I ...

Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of care Triplet Combination with mipletamig continues to outperform ...

U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and ...

A new study raises critical questions about the effectiveness of the Centers for Medicare and Medicaid Services' (CMS) sepsis quality measure, known as the Severe Sepsis/Septic Shock Management Bundle ...

Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports F1.